LianBio (LIANY): Cash & Equivalents
Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$79.22M
As of 2022-12-31
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $79.22M | -65.3% | 2023-03-28, Balance as of period end |
| 2021-12-31 | $228.18M | -10.3% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $254.35M | n/a | 2022-03-31, Balance as of period end |